{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T09:45:25Z","timestamp":1778924725081,"version":"3.51.4"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,8,7]],"date-time":"2018-08-07T00:00:00Z","timestamp":1533600000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Radiat Oncol"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1186\/s13014-018-1084-0","type":"journal-article","created":{"date-parts":[[2018,8,7]],"date-time":"2018-08-07T09:15:18Z","timestamp":1533633318000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Hyperfractionated abdominal reirradiation for gastrointestinal malignancies"],"prefix":"10.1186","volume":"13","author":[{"given":"Andrew","family":"Hunt","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Prajnan","family":"Das","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bruce D.","family":"Minsky","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eugene J.","family":"Koay","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sunil","family":"Krishnan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joseph M.","family":"Herman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cullen","family":"Taniguchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Albert","family":"Koong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Grace L.","family":"Smith","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emma B.","family":"Holliday","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,8,7]]},"reference":[{"key":"1084_CR1","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1016\/j.gassur.2005.09.016","volume":"10","author":"S Hishinuma","year":"2006","unstructured":"Hishinuma S, Ogata Y, Tomikawa M, Ozawa I, Hirabayashi K, Igarashi S. Patterns of recurrence after curative resection of pancreatic cancer, based on autopsy findings. J Gastrointest Surg Off J Soc Surg Aliment Tract. 2006;10:511\u20138.","journal-title":"J Gastrointest Surg Off J Soc Surg Aliment Tract"},{"key":"1084_CR2","doi-asserted-by":"publisher","first-page":"1200","DOI":"10.1056\/NEJMoa032295","volume":"350","author":"JP Neoptolemos","year":"2004","unstructured":"Neoptolemos JP, Stocken DD, Friess H, Bassi C, Dunn JA, Hickey H, et al. A randomized trial of chemoradiotherapy and chemotherapy after resection of pancreatic cancer. N Engl J Med. 2004;350:1200\u201310.","journal-title":"N Engl J Med"},{"key":"1084_CR3","doi-asserted-by":"publisher","first-page":"4450","DOI":"10.1200\/JCO.2010.30.3446","volume":"28","author":"J-L Van Laethem","year":"2010","unstructured":"Van Laethem J-L, Hammel P, Mornex F, Azria D, Van Tienhoven G, Vergauwe P, et al. Adjuvant gemcitabine alone versus gemcitabine-based chemoradiotherapy after curative resection for pancreatic cancer: a randomized EORTC-40013-22012\/FFCD-9203\/GERCOR phase II study. J Clin Oncol Off J Am Soc Clin Oncol. 2010;28:4450\u20136.","journal-title":"J Clin Oncol Off J Am Soc Clin Oncol"},{"key":"1084_CR4","doi-asserted-by":"publisher","first-page":"664","DOI":"10.1016\/j.jamcollsurg.2014.03.062","volume":"219","author":"G Spolverato","year":"2014","unstructured":"Spolverato G, Ejaz A, Kim Y, Squires MH, Poultsides GA, Fields RC, et al. Rates and patterns of recurrence after curative intent resection for gastric cancer: a United States multi-institutional analysis. J Am Coll Surg. 2014;219:664\u201375.","journal-title":"J Am Coll Surg"},{"key":"1084_CR5","doi-asserted-by":"publisher","first-page":"503","DOI":"10.21147\/j.issn.1000-9604.2016.05.05","volume":"28","author":"C-H Shin","year":"2016","unstructured":"Shin C-H, Lee W-Y, Hong S-W, Chang Y-G. Characteristics of gastric cancer recurrence five or more years after curative gastrectomy. Chin J Cancer Res. 2016;28:503\u201310.","journal-title":"Chin J Cancer Res"},{"key":"1084_CR6","doi-asserted-by":"publisher","first-page":"1029","DOI":"10.1007\/s10350-004-6355-1","volume":"45","author":"GJC Harris","year":"2002","unstructured":"Harris GJC, Church JM, Senagore AJ, Lavery IC, Hull TL, Strong SA, et al. Factors affecting local recurrence of colonic adenocarcinoma. Dis Colon Rectum. 2002;45:1029\u201334.","journal-title":"Dis Colon Rectum"},{"key":"1084_CR7","unstructured":"National Comprehensive Cancer Network Guidelines Version 3.2017 Pancreatic Adenocarcinoma [Internet]. Available from: \n                    https:\/\/www.nccn.org\/professionals\/physician_gls\/pdf\/pancreatic.pdf\n                    \n                  . [cited 4 Jan 2018]."},{"key":"1084_CR8","unstructured":"National Comprehensive Cancer Network Guidelines Version 5.2017 Gastric Cancer [Internet]. Available from: \n                    https:\/\/www.nccn.org\/professionals\/physician_gls\/pdf\/gastric.pdf\n                    \n                  , [cited 4 Jan 2018]"},{"key":"1084_CR9","unstructured":"NCCN. National Comprehensive Cancer Network Guidelines Version 2.2017 Colon Cancer [Internet]. Natl. Compr. Cancer Netw. Available from: \n                    https:\/\/www.nccn.org\/professionals\/physician_gls\/pdf\/colon.pdf\n                    \n                  . [cited 11 Jul 2017]"},{"key":"1084_CR10","unstructured":"National Comprehensive Cancer Network Guidelines- Hepatobiliary Cancers [Internet]. Available from: \n                    https:\/\/www.nccn.org\/professionals\/physician_gls\/pdf\/hepatobiliary.pdf\n                    \n                  . [cited 2 Jan 2017]"},{"key":"1084_CR11","doi-asserted-by":"publisher","first-page":"1983","DOI":"10.1200\/JCO.2008.20.0691","volume":"27","author":"T Tanvetyanon","year":"2009","unstructured":"Tanvetyanon T, Padhya T, McCaffrey J, Zhu W, Boulware D, Deconti R, et al. Prognostic factors for survival after salvage reirradiation of head and neck cancer. J Clin Oncol Off J Am Soc Clin Oncol. 2009;27:1983\u201391.","journal-title":"J Clin Oncol Off J Am Soc Clin Oncol"},{"key":"1084_CR12","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1016\/j.ijrobp.2008.04.021","volume":"73","author":"EP Sulman","year":"2009","unstructured":"Sulman EP, Schwartz DL, Le TT, Ang KK, Morrison WH, Rosenthal DI, et al. IMRT reirradiation of head and neck cancer-disease control and morbidity outcomes. Int J Radiat Oncol Biol Phys. 2009;73:399\u2013409.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"1084_CR13","doi-asserted-by":"publisher","first-page":"1117","DOI":"10.1016\/j.ijrobp.2016.03.015","volume":"95","author":"V Takiar","year":"2016","unstructured":"Takiar V, Garden AS, Ma D, Morrison WH, Edson M, Zafereo ME, et al. Reirradiation of head and neck cancers with intensity modulated radiation therapy: outcomes and analyses. Int J Radiat Oncol Biol Phys. 2016;95:1117\u201331.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"1084_CR14","doi-asserted-by":"publisher","first-page":"5518","DOI":"10.1200\/JCO.2007.15.0102","volume":"26","author":"F Janot","year":"2008","unstructured":"Janot F, de Raucourt D, Benhamou E, Ferron C, Dolivet G, Bensadoun R-J, et al. Randomized trial of postoperative reirradiation combined with chemotherapy after salvage surgery compared with salvage surgery alone in head and neck carcinoma. J Clin Oncol Off J Am Soc Clin Oncol. 2008;26:5518\u201323.","journal-title":"J Clin Oncol Off J Am Soc Clin Oncol"},{"key":"1084_CR15","doi-asserted-by":"publisher","first-page":"4800","DOI":"10.1200\/JCO.2006.07.9194","volume":"25","author":"CJ Langer","year":"2007","unstructured":"Langer CJ, Harris J, Horwitz EM, Nicolaou N, Kies M, Curran W, et al. Phase II study of low-dose paclitaxel and cisplatin in combination with split-course concomitant twice-daily reirradiation in recurrent squamous cell carcinoma of the head and neck: results of radiation therapy oncology group protocol 9911. J Clin Oncol Off J Am Soc Clin Oncol. 2007;25:4800\u20135.","journal-title":"J Clin Oncol Off J Am Soc Clin Oncol"},{"key":"1084_CR16","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1007\/s00066-009-1969-9","volume":"185","author":"G Henke","year":"2009","unstructured":"Henke G, Paulsen F, Steinbach JP, Ganswindt U, Isijanov H, Kortmann R-D, et al. Hypofractionated reirradiation for recurrent malignant glioma. Strahlenther Onkol Organ Dtsch Rontgengesellschaft Al. 2009;185:113\u20139.","journal-title":"Strahlenther Onkol Organ Dtsch Rontgengesellschaft Al"},{"key":"1084_CR17","doi-asserted-by":"publisher","first-page":"1381","DOI":"10.1016\/j.ijrobp.2007.12.018","volume":"71","author":"AC Paulino","year":"2008","unstructured":"Paulino AC, Mai WY, Chintagumpala M, Taher A, Teh BS. Radiation-induced malignant gliomas: is there a role for reirradiation? Int J Radiat Oncol Biol Phys. 2008;71:1381\u20137.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"1084_CR18","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1007\/s00066-009-1753-x","volume":"185","author":"E Fokas","year":"2009","unstructured":"Fokas E, Wacker U, Gross MW, Henzel M, Encheva E, Engenhart-Cabillic R. Hypofractionated stereotactic reirradiation of recurrent glioblastomas\u00a0: a beneficial treatment option after high-dose radiotherapy? Strahlenther Onkol Organ Dtsch Rontgengesellschaft Al. 2009;185:235\u201340.","journal-title":"Strahlenther Onkol Organ Dtsch Rontgengesellschaft Al."},{"key":"1084_CR19","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1186\/1748-717X-3-28","volume":"3","author":"F W\u00fcrschmidt","year":"2008","unstructured":"W\u00fcrschmidt F, Dahle J, Petersen C, Wenzel C, Kretschmer M, Bastian C. Reirradiation of recurrent breast cancer with and without concurrent chemotherapy. Radiat Oncol Lond Engl. 2008;3:28.","journal-title":"Radiat Oncol Lond Engl."},{"key":"1084_CR20","first-page":"33","volume":"14","author":"R Cetingoz","year":"2009","unstructured":"Cetingoz R, Arican-Alicikus Z, Nur-Demiral A, Durmak-Isman B, Bakis-Altas B, Kinay M. Is re-irradiation effective in symptomatic local recurrence of non small cell lung cancer patients? A single institution experience and review of the literature. J BUON Off J Balk Union Oncol. 2009;14:33\u201340.","journal-title":"J BUON Off J Balk Union Oncol"},{"key":"1084_CR21","doi-asserted-by":"publisher","first-page":"1129","DOI":"10.1016\/j.ijrobp.2005.09.017","volume":"64","author":"V Valentini","year":"2006","unstructured":"Valentini V, Morganti AG, Gambacorta MA, Mohiuddin M, Doglietto GB, Coco C, et al. Preoperative hyperfractionated chemoradiation for locally recurrent rectal cancer in patients previously irradiated to the pelvis: a multicentric phase II study. Int J Radiat Oncol Biol Phys. 2006;64:1129\u201339.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"1084_CR22","doi-asserted-by":"publisher","first-page":"1159","DOI":"10.1016\/0360-3016(93)90538-7","volume":"27","author":"M Mohiuddin","year":"1993","unstructured":"Mohiuddin M, Lingareddy V, Rakinic J, Marks G. Reirradiation for rectal cancer and surgical resection after ultra high doses. Int J Radiat Oncol Biol Phys. 1993;27:1159\u201363.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"1084_CR23","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1016\/S0360-3016(97)00340-4","volume":"39","author":"M Mohiuddin","year":"1997","unstructured":"Mohiuddin M, Marks GM, Lingareddy V, Marks J. Curative surgical resection following reirradiation for recurrent rectal cancer. Int J Radiat Oncol Biol Phys. 1997;39:643\u20139.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"1084_CR24","doi-asserted-by":"publisher","first-page":"1144","DOI":"10.1002\/cncr.10799","volume":"95","author":"M Mohiuddin","year":"2002","unstructured":"Mohiuddin M, Marks G, Marks J. Long-term results of reirradiation for patients with recurrent rectal carcinoma. Cancer. 2002;95:1144\u201350.","journal-title":"Cancer"},{"key":"1084_CR25","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1016\/S0360-3016(97)00058-8","volume":"38","author":"V Lingareddy","year":"1997","unstructured":"Lingareddy V, Ahmad NR, Mohiuddin M. Palliative reirradiation for recurrent rectal cancer. Int J Radiat Oncol Biol Phys. 1997;38:785\u201390.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"1084_CR26","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/j.ijrobp.2009.04.056","volume":"77","author":"P Das","year":"2010","unstructured":"Das P, Delclos ME, Skibber JM, Rodriguez-Bigas MA, Feig BW, Chang GJ, et al. Hyperfractionated accelerated radiotherapy for rectal cancer in patients with prior pelvic irradiation. Int J Radiat Oncol Biol Phys. 2010;77:60\u20135.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"1084_CR27","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1016\/j.radonc.2016.12.015","volume":"122","author":"R Tao","year":"2017","unstructured":"Tao R, Tsai CJ, Jensen G, Eng C, Kopetz S, Overman MJ, et al. Hyperfractionated accelerated reirradiation for rectal cancer: an analysis of outcomes and toxicity. Radiother Oncol J Eur Soc Ther Radiol Oncol. 2017;122:146\u201351.","journal-title":"Radiother Oncol J Eur Soc Ther Radiol Oncol."},{"key":"1084_CR28","doi-asserted-by":"crossref","unstructured":"Osborne EM, Eng C, Skibber JM, Rodriguez-Bigas MA, Chang GJ, Nancy You Y-Q, et al. Hyperfractionated Accelerated Reirradiation for Patients With Recurrent Anal Cancer Previously Treated With Definitive Chemoradiation. Am J Clin Oncol.2018;41(7):632\u201337.","DOI":"10.1097\/COC.0000000000000338"},{"key":"1084_CR29","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1186\/1748-717X-4-55","volume":"4","author":"W Haque","year":"2009","unstructured":"Haque W, Crane CH, Krishnan S, Delclos ME, Javle M, Garrett CR, et al. Reirradiation to the abdomen for gastrointestinal malignancies. Radiat Oncol Lond Engl. 2009;4:55.","journal-title":"Radiat Oncol Lond Engl."},{"key":"1084_CR30","unstructured":"Common Terminology Criteria for Adverse Events (CTCAE) Version 4 [Internet]. 2009. Available from: \n                    https:\/\/www.eortc.be\/services\/doc\/ctc\/CTCAE_4.03_2010-06-14_QuickReference_5x7.pdf\n                    \n                  . [cited 4 Jan 2018]."},{"key":"1084_CR31","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1186\/s13014-015-0489-2","volume":"10","author":"A Elhammali","year":"2015","unstructured":"Elhammali A, Patel M, Weinberg B, Verma V, Liu J, Olsen JR, et al. Late gastrointestinal tissue effects after hypofractionated radiation therapy of the pancreas. Radiat Oncol Lond Engl. 2015;10:186.","journal-title":"Radiat Oncol Lond Engl."},{"key":"1084_CR32","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/S0167-8140(99)00124-3","volume":"53","author":"S Dische","year":"1999","unstructured":"Dische S, Saunders MI, Sealy R, Werner ID, Verma N, Foy C, et al. Carcinoma of the cervix and the use of hyperbaric oxygen with radiotherapy: a report of a randomised controlled trial. Radiother Oncol J Eur Soc Ther Radiol Oncol. 1999;53:93\u20138.","journal-title":"Radiother Oncol J Eur Soc Ther Radiol Oncol."},{"key":"1084_CR33","first-page":"521","volume":"169","author":"SM Deore","year":"1993","unstructured":"Deore SM, Shrivastava SK, Supe SJ, Viswanathan PS, Dinshaw KA. Alpha\/beta value and importance of dose per fraction for the late rectal and recto-sigmoid complications. Strahlenther Onkol Organ Dtsch Rontgengesellschaft Al. 1993;169:521\u20136.","journal-title":"Strahlenther Onkol Organ Dtsch Rontgengesellschaft Al."},{"key":"1084_CR34","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1016\/j.radonc.2017.04.024","volume":"123","author":"DLP Holyoake","year":"2017","unstructured":"Holyoake DLP, Aznar M, Mukherjee S, Partridge M, Hawkins MA. Modelling duodenum radiotherapy toxicity using cohort dose-volume-histogram data. Radiother Oncol J Eur Soc Ther Radiol Oncol. 2017;123:431\u20137.","journal-title":"Radiother Oncol J Eur Soc Ther Radiol Oncol"},{"key":"1084_CR35","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1080\/01621459.1958.10501452","volume":"53","author":"E Kaplan","year":"1958","unstructured":"Kaplan E, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Associ. 1958;53:457\u201381.","journal-title":"J Am Stat Associ"},{"key":"1084_CR36","doi-asserted-by":"publisher","first-page":"1331","DOI":"10.1016\/0360-3016(88)90228-3","volume":"15","author":"JD Cox","year":"1988","unstructured":"Cox JD, Guse C, Asbell S, Rubin P, Sause WT. Tolerance of pelvic normal tissues to hyperfractionated radiation therapy: results of protocol 83-08 of the radiation therapy oncology group. Int J Radiat Oncol Biol Phys. 1988;15:1331\u20136.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"1084_CR37","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1186\/1748-717X-7-74","volume":"7","author":"CE Lominska","year":"2012","unstructured":"Lominska CE, Unger K, Nasr NM, Haddad N, Gagnon G. Stereotactic body radiation therapy for reirradiation of localized adenocarcinoma of the pancreas. Radiat Oncol Lond Engl. 2012;7:74.","journal-title":"Radiat Oncol Lond Engl"},{"key":"1084_CR38","doi-asserted-by":"publisher","first-page":"283","DOI":"10.7150\/jca.13295","volume":"7","author":"N Dagoglu","year":"2016","unstructured":"Dagoglu N, Callery M, Moser J, Tseng J, Kent T, Bullock A, et al. Stereotactic body radiotherapy (SBRT) Reirradiation for recurrent pancreas Cancer. J Cancer. 2016;7:283\u20138.","journal-title":"J Cancer"},{"key":"1084_CR39","first-page":"343","volume":"4","author":"AT Wild","year":"2013","unstructured":"Wild AT, Hiniker SM, Chang DT, Tran PT, Khashab MA, Limaye MR, et al. Re-irradiation with stereotactic body radiation therapy as a novel treatment option for isolated local recurrence of pancreatic cancer after multimodality therapy: experience from two institutions. J Gastrointest Oncol. 2013;4:343\u201351.","journal-title":"J Gastrointest Oncol"},{"key":"1084_CR40","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.adro.2017.01.003","volume":"2","author":"AJ Koong","year":"2017","unstructured":"Koong AJ, Toesca DAS, von Eyben R, Pollom EL, Chang DT. Reirradiation with stereotactic body radiation therapy after prior conventional fractionation radiation for locally recurrent pancreatic adenocarcinoma. Adv Radiat Oncol. 2017;2:27\u201336.","journal-title":"Adv Radiat Oncol"}],"container-title":["Radiation Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13014-018-1084-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s13014-018-1084-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13014-018-1084-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,6]],"date-time":"2019-08-06T19:13:35Z","timestamp":1565118815000},"score":1,"resource":{"primary":{"URL":"https:\/\/ro-journal.biomedcentral.com\/articles\/10.1186\/s13014-018-1084-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,8,7]]},"references-count":40,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["1084"],"URL":"https:\/\/doi.org\/10.1186\/s13014-018-1084-0","relation":{},"ISSN":["1748-717X"],"issn-type":[{"value":"1748-717X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,8,7]]},"assertion":[{"value":"8 March 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 July 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 August 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The University of Texas MD Anderson Cancer Center Institutional Review Board approval was obtained prior to collecting data for this study. The University of Texas MD Anderson Cancer Center Institutional Review Board awarded a waiver of informed consent due to the retrospective nature of this study.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"143"}}